Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 49 | 2024 | 413 | 14.170 |
Why?
|
Adenoma | 22 | 2021 | 89 | 7.800 |
Why?
|
Colonic Polyps | 17 | 2021 | 67 | 7.580 |
Why?
|
Stomach Neoplasms | 55 | 2024 | 192 | 7.430 |
Why?
|
Helicobacter pylori | 27 | 2024 | 105 | 4.700 |
Why?
|
Crocus | 7 | 2023 | 16 | 4.360 |
Why?
|
Gastrointestinal Diseases | 6 | 2023 | 41 | 4.140 |
Why?
|
Colonic Neoplasms | 14 | 2021 | 181 | 4.050 |
Why?
|
DNA Methylation | 17 | 2024 | 301 | 3.890 |
Why?
|
Helicobacter Infections | 18 | 2024 | 74 | 3.600 |
Why?
|
Microsatellite Instability | 12 | 2024 | 43 | 3.590 |
Why?
|
Gene Expression Regulation, Neoplastic | 32 | 2022 | 781 | 2.700 |
Why?
|
Humans | 162 | 2024 | 34853 | 2.670 |
Why?
|
Colonoscopy | 15 | 2021 | 98 | 2.440 |
Why?
|
Middle Aged | 61 | 2023 | 9642 | 2.320 |
Why?
|
Colitis | 3 | 2021 | 64 | 2.250 |
Why?
|
Male | 78 | 2023 | 18870 | 2.080 |
Why?
|
Aged | 48 | 2022 | 6448 | 1.920 |
Why?
|
Female | 76 | 2023 | 19873 | 1.900 |
Why?
|
Carcinoma | 6 | 2024 | 94 | 1.750 |
Why?
|
Adenocarcinoma | 12 | 2018 | 239 | 1.700 |
Why?
|
Gastric Mucosa | 14 | 2023 | 50 | 1.580 |
Why?
|
Adenomatous Polyps | 3 | 2016 | 12 | 1.560 |
Why?
|
Promoter Regions, Genetic | 12 | 2020 | 484 | 1.550 |
Why?
|
Precancerous Conditions | 5 | 2023 | 81 | 1.540 |
Why?
|
Risk Factors | 19 | 2021 | 3414 | 1.520 |
Why?
|
Plant Extracts | 4 | 2022 | 250 | 1.440 |
Why?
|
Mutation | 8 | 2023 | 1023 | 1.430 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 85 | 1.430 |
Why?
|
Bacteria | 3 | 2021 | 245 | 1.390 |
Why?
|
Transcription Factors | 7 | 2023 | 653 | 1.390 |
Why?
|
Retrospective Studies | 16 | 2023 | 1961 | 1.340 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 39 | 1.320 |
Why?
|
Neoplasms | 3 | 2022 | 1033 | 1.270 |
Why?
|
Antigens, Bacterial | 12 | 2019 | 129 | 1.270 |
Why?
|
Apoptosis | 18 | 2022 | 1317 | 1.250 |
Why?
|
Liver Diseases | 2 | 2023 | 31 | 1.190 |
Why?
|
MicroRNAs | 11 | 2022 | 386 | 1.190 |
Why?
|
Proto-Oncogene Proteins | 5 | 2015 | 229 | 1.150 |
Why?
|
Cell Line, Tumor | 43 | 2022 | 2128 | 1.130 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 24 | 1.120 |
Why?
|
Adult | 34 | 2023 | 11034 | 1.080 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2020 | 638 | 1.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 176 | 1.040 |
Why?
|
Aged, 80 and over | 20 | 2019 | 2333 | 1.040 |
Why?
|
Lymphatic Metastasis | 5 | 2021 | 63 | 1.030 |
Why?
|
Dextran Sulfate | 2 | 2021 | 14 | 1.020 |
Why?
|
Health Status Disparities | 3 | 2020 | 583 | 1.020 |
Why?
|
Neoplasm Staging | 8 | 2021 | 269 | 1.020 |
Why?
|
Ferritins | 2 | 2022 | 54 | 0.980 |
Why?
|
Peptide Hormones | 7 | 2020 | 19 | 0.980 |
Why?
|
Nuclear Proteins | 9 | 2023 | 287 | 0.970 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2019 | 23 | 0.970 |
Why?
|
Life Style | 3 | 2017 | 288 | 0.960 |
Why?
|
Gene Expression Profiling | 7 | 2021 | 600 | 0.960 |
Why?
|
Prevalence | 9 | 2020 | 1425 | 0.960 |
Why?
|
Colon | 4 | 2021 | 98 | 0.960 |
Why?
|
Biological Products | 2 | 2023 | 67 | 0.950 |
Why?
|
Nutrigenomics | 1 | 2023 | 2 | 0.940 |
Why?
|
beta Catenin | 2 | 2020 | 46 | 0.940 |
Why?
|
Cell Proliferation | 26 | 2022 | 1149 | 0.940 |
Why?
|
Chromosome Aberrations | 2 | 2014 | 56 | 0.900 |
Why?
|
Age Factors | 8 | 2021 | 1007 | 0.890 |
Why?
|
DNA-Binding Proteins | 5 | 2023 | 522 | 0.850 |
Why?
|
District of Columbia | 8 | 2021 | 68 | 0.850 |
Why?
|
Tumor Suppressor Proteins | 6 | 2022 | 184 | 0.840 |
Why?
|
Stomach | 6 | 2020 | 43 | 0.840 |
Why?
|
Risk Assessment | 6 | 2021 | 727 | 0.830 |
Why?
|
Prognosis | 7 | 2024 | 707 | 0.830 |
Why?
|
Dietary Supplements | 1 | 2023 | 196 | 0.820 |
Why?
|
Case-Control Studies | 13 | 2022 | 1056 | 0.810 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 12 | 0.800 |
Why?
|
Neoplasm Proteins | 9 | 2019 | 203 | 0.800 |
Why?
|
Enzymes | 1 | 2021 | 30 | 0.800 |
Why?
|
RNA, Small Interfering | 4 | 2021 | 391 | 0.790 |
Why?
|
Lymph Nodes | 1 | 2021 | 67 | 0.790 |
Why?
|
Condylomata Acuminata | 1 | 2020 | 6 | 0.780 |
Why?
|
Urban Health | 3 | 2015 | 86 | 0.780 |
Why?
|
Cyclooxygenase 2 | 4 | 2013 | 92 | 0.770 |
Why?
|
Human papillomavirus 16 | 1 | 2020 | 34 | 0.770 |
Why?
|
Epithelial Cells | 13 | 2020 | 366 | 0.750 |
Why?
|
Microsatellite Repeats | 3 | 2024 | 51 | 0.750 |
Why?
|
C-Reactive Protein | 1 | 2021 | 147 | 0.740 |
Why?
|
Uterine Diseases | 1 | 2019 | 5 | 0.740 |
Why?
|
Polyps | 1 | 2019 | 9 | 0.740 |
Why?
|
Anus Neoplasms | 1 | 2020 | 47 | 0.730 |
Why?
|
Carotenoids | 2 | 2020 | 70 | 0.730 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 49 | 0.720 |
Why?
|
Crohn Disease | 1 | 2020 | 55 | 0.720 |
Why?
|
Incidence | 7 | 2021 | 882 | 0.710 |
Why?
|
Anemia, Sickle Cell | 1 | 2021 | 169 | 0.710 |
Why?
|
Spices | 1 | 2019 | 8 | 0.700 |
Why?
|
Adenomatous Polyposis Coli Protein | 2 | 2020 | 9 | 0.700 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2018 | 180 | 0.700 |
Why?
|
Odds Ratio | 6 | 2020 | 517 | 0.700 |
Why?
|
Mice | 24 | 2024 | 5668 | 0.700 |
Why?
|
Logistic Models | 7 | 2020 | 894 | 0.700 |
Why?
|
Sequence Analysis, DNA | 4 | 2019 | 455 | 0.690 |
Why?
|
Epigenesis, Genetic | 5 | 2018 | 198 | 0.680 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 147 | 0.670 |
Why?
|
Antiviral Agents | 1 | 2020 | 148 | 0.670 |
Why?
|
Bacterial Proteins | 12 | 2019 | 520 | 0.670 |
Why?
|
Liver | 1 | 2021 | 447 | 0.660 |
Why?
|
Liver Neoplasms | 1 | 2021 | 195 | 0.650 |
Why?
|
Histones | 4 | 2017 | 177 | 0.650 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 465 | 0.650 |
Why?
|
Animals | 34 | 2024 | 14307 | 0.640 |
Why?
|
Repressor Proteins | 4 | 2021 | 226 | 0.640 |
Why?
|
Medication Adherence | 1 | 2020 | 165 | 0.640 |
Why?
|
United States | 13 | 2020 | 3894 | 0.630 |
Why?
|
Down-Regulation | 8 | 2021 | 420 | 0.630 |
Why?
|
Digestive System Neoplasms | 1 | 2017 | 4 | 0.630 |
Why?
|
Cell Movement | 13 | 2021 | 545 | 0.610 |
Why?
|
Membrane Glycoproteins | 1 | 2018 | 197 | 0.610 |
Why?
|
Antineoplastic Agents | 7 | 2020 | 756 | 0.610 |
Why?
|
Feces | 2 | 2016 | 110 | 0.600 |
Why?
|
Hepacivirus | 1 | 2017 | 59 | 0.600 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 51 | 0.600 |
Why?
|
Mitochondria | 3 | 2019 | 454 | 0.590 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2019 | 89 | 0.590 |
Why?
|
Iran | 7 | 2017 | 183 | 0.580 |
Why?
|
Fatty Liver | 1 | 2017 | 56 | 0.580 |
Why?
|
Genes, Tumor Suppressor | 2 | 2013 | 58 | 0.580 |
Why?
|
DNA Helicases | 2 | 2013 | 40 | 0.580 |
Why?
|
Pancreatic Cyst | 1 | 2016 | 3 | 0.570 |
Why?
|
Papillomavirus Infections | 1 | 2020 | 316 | 0.570 |
Why?
|
Pathology, Clinical | 1 | 2015 | 4 | 0.560 |
Why?
|
Lymph Node Excision | 1 | 2015 | 25 | 0.560 |
Why?
|
Hospitals, University | 1 | 2015 | 38 | 0.550 |
Why?
|
Diverticulosis, Colonic | 1 | 2015 | 3 | 0.550 |
Why?
|
Receptor, EphA6 | 1 | 2015 | 2 | 0.540 |
Why?
|
Genome, Human | 2 | 2014 | 112 | 0.530 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 187 | 0.530 |
Why?
|
Tumor Cells, Cultured | 10 | 2020 | 480 | 0.530 |
Why?
|
CpG Islands | 4 | 2018 | 91 | 0.520 |
Why?
|
Haplotypes | 3 | 2017 | 152 | 0.520 |
Why?
|
Homeodomain Proteins | 4 | 2019 | 128 | 0.520 |
Why?
|
Sex Factors | 5 | 2020 | 859 | 0.520 |
Why?
|
Body Mass Index | 2 | 2020 | 775 | 0.510 |
Why?
|
Genetic Variation | 1 | 2017 | 328 | 0.500 |
Why?
|
Obesity | 3 | 2021 | 965 | 0.500 |
Why?
|
Immunohistochemistry | 10 | 2018 | 859 | 0.500 |
Why?
|
Chi-Square Distribution | 6 | 2015 | 213 | 0.500 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 105 | 0.490 |
Why?
|
Nerve Tissue Proteins | 2 | 2013 | 338 | 0.490 |
Why?
|
Proteins | 3 | 2013 | 352 | 0.490 |
Why?
|
MutS Homolog 2 Protein | 4 | 2024 | 30 | 0.480 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2022 | 200 | 0.480 |
Why?
|
Genetic Markers | 2 | 2014 | 118 | 0.470 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2019 | 166 | 0.470 |
Why?
|
Gene Amplification | 2 | 2012 | 24 | 0.470 |
Why?
|
ras Proteins | 2 | 2014 | 49 | 0.460 |
Why?
|
Comorbidity | 3 | 2021 | 606 | 0.450 |
Why?
|
Multivariate Analysis | 4 | 2017 | 570 | 0.450 |
Why?
|
Chromosomes, Human, X | 1 | 2012 | 14 | 0.440 |
Why?
|
Gastrointestinal Tract | 2 | 2023 | 59 | 0.440 |
Why?
|
Gastroesophageal Reflux | 1 | 2012 | 29 | 0.440 |
Why?
|
Phylogeny | 4 | 2021 | 612 | 0.440 |
Why?
|
Cohort Studies | 6 | 2023 | 1422 | 0.440 |
Why?
|
Receptors, Calcitriol | 2 | 2019 | 59 | 0.430 |
Why?
|
HCT116 Cells | 4 | 2021 | 34 | 0.430 |
Why?
|
Proteomics | 6 | 2021 | 302 | 0.420 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 58 | 0.420 |
Why?
|
Prospective Studies | 5 | 2023 | 1353 | 0.420 |
Why?
|
Diverticulum, Colon | 2 | 2022 | 3 | 0.420 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 1530 | 0.410 |
Why?
|
Diarrhea | 2 | 2022 | 84 | 0.410 |
Why?
|
Trans-Activators | 4 | 2024 | 167 | 0.410 |
Why?
|
Cation Transport Proteins | 1 | 2011 | 30 | 0.400 |
Why?
|
Overweight | 1 | 2014 | 233 | 0.400 |
Why?
|
Butyrates | 1 | 2011 | 31 | 0.400 |
Why?
|
Neoplasm Invasiveness | 8 | 2021 | 247 | 0.400 |
Why?
|
Minority Groups | 1 | 2016 | 537 | 0.400 |
Why?
|
Genetic Predisposition to Disease | 6 | 2017 | 528 | 0.390 |
Why?
|
Genes, APC | 2 | 2009 | 14 | 0.390 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 44 | 0.390 |
Why?
|
Carrier Proteins | 5 | 2019 | 287 | 0.380 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 124 | 0.370 |
Why?
|
Chromosomal Instability | 2 | 2010 | 21 | 0.370 |
Why?
|
Disease Progression | 7 | 2023 | 580 | 0.360 |
Why?
|
Autophagy | 3 | 2022 | 111 | 0.360 |
Why?
|
Vitamin D | 1 | 2011 | 176 | 0.360 |
Why?
|
Carcinoma in Situ | 1 | 2009 | 13 | 0.350 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2013 | 298 | 0.350 |
Why?
|
Databases, Genetic | 2 | 2021 | 90 | 0.350 |
Why?
|
Disease Models, Animal | 4 | 2021 | 1300 | 0.350 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 69 | 0.350 |
Why?
|
Apoptosis Inducing Factor | 1 | 2008 | 7 | 0.350 |
Why?
|
Young Adult | 5 | 2021 | 4012 | 0.340 |
Why?
|
Gene Silencing | 3 | 2021 | 143 | 0.340 |
Why?
|
Inflammation | 4 | 2022 | 577 | 0.330 |
Why?
|
Hospitalization | 2 | 2022 | 370 | 0.330 |
Why?
|
Histone Deacetylases | 1 | 2008 | 52 | 0.330 |
Why?
|
Peptide Library | 2 | 2018 | 25 | 0.320 |
Why?
|
Lysosomes | 2 | 2019 | 80 | 0.320 |
Why?
|
Tissue Array Analysis | 4 | 2018 | 65 | 0.320 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 424 | 0.320 |
Why?
|
Signal Transduction | 8 | 2019 | 1802 | 0.310 |
Why?
|
Aspirin | 2 | 2022 | 45 | 0.310 |
Why?
|
Azacitidine | 2 | 2020 | 21 | 0.310 |
Why?
|
Stress, Psychological | 1 | 2013 | 541 | 0.310 |
Why?
|
Mass Screening | 3 | 2019 | 427 | 0.310 |
Why?
|
Tetrahydrofolates | 1 | 2007 | 1 | 0.310 |
Why?
|
Transcription Factor AP-1 | 1 | 2007 | 33 | 0.310 |
Why?
|
Body Weight | 2 | 2021 | 404 | 0.310 |
Why?
|
Survival Rate | 3 | 2020 | 310 | 0.300 |
Why?
|
Early Detection of Cancer | 3 | 2020 | 292 | 0.300 |
Why?
|
Folic Acid | 1 | 2007 | 46 | 0.300 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2020 | 34 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 139 | 0.300 |
Why?
|
Cell Line | 11 | 2021 | 1289 | 0.300 |
Why?
|
Computational Biology | 4 | 2021 | 275 | 0.290 |
Why?
|
Time Factors | 4 | 2017 | 1681 | 0.290 |
Why?
|
Intestinal Mucosa | 2 | 2021 | 115 | 0.290 |
Why?
|
Genotype | 4 | 2020 | 641 | 0.290 |
Why?
|
Follow-Up Studies | 2 | 2023 | 964 | 0.280 |
Why?
|
Blotting, Western | 8 | 2012 | 834 | 0.280 |
Why?
|
Patient Compliance | 2 | 2019 | 202 | 0.270 |
Why?
|
Biopsy | 3 | 2019 | 151 | 0.270 |
Why?
|
Fluorouracil | 1 | 2005 | 32 | 0.270 |
Why?
|
Stomach Ulcer | 1 | 2004 | 5 | 0.260 |
Why?
|
Gastritis | 1 | 2004 | 11 | 0.260 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2023 | 25 | 0.250 |
Why?
|
RNA, Messenger | 7 | 2024 | 1152 | 0.250 |
Why?
|
Cell Survival | 7 | 2020 | 818 | 0.250 |
Why?
|
Administration, Oral | 2 | 2023 | 212 | 0.250 |
Why?
|
Alleles | 2 | 2020 | 284 | 0.250 |
Why?
|
DNA, Viral | 2 | 2020 | 295 | 0.250 |
Why?
|
Translocation, Genetic | 1 | 2004 | 39 | 0.250 |
Why?
|
Scavenger Receptors, Class E | 1 | 2024 | 4 | 0.250 |
Why?
|
Cytokines | 2 | 2021 | 569 | 0.250 |
Why?
|
Vomiting | 1 | 2023 | 13 | 0.240 |
Why?
|
Demography | 2 | 2016 | 167 | 0.240 |
Why?
|
Gene Dosage | 2 | 2014 | 74 | 0.240 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2024 | 15 | 0.240 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2019 | 146 | 0.240 |
Why?
|
Adenosine | 1 | 2024 | 54 | 0.240 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2003 | 11 | 0.240 |
Why?
|
Comparative Genomic Hybridization | 2 | 2014 | 17 | 0.230 |
Why?
|
Virulence | 1 | 2024 | 221 | 0.230 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 112 | 0.230 |
Why?
|
Oxidative Stress | 2 | 2016 | 874 | 0.230 |
Why?
|
Diet | 2 | 2023 | 747 | 0.220 |
Why?
|
Histone Code | 1 | 2022 | 12 | 0.220 |
Why?
|
Troponin | 1 | 2022 | 15 | 0.220 |
Why?
|
Sirtuin 1 | 1 | 2022 | 32 | 0.220 |
Why?
|
Histone Deacetylase 1 | 2 | 2020 | 14 | 0.220 |
Why?
|
Retroelements | 1 | 2021 | 12 | 0.210 |
Why?
|
Phenotype | 2 | 2017 | 650 | 0.210 |
Why?
|
Caspases | 1 | 2002 | 132 | 0.210 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2021 | 3 | 0.210 |
Why?
|
Naphthalimides | 1 | 2021 | 3 | 0.210 |
Why?
|
STAT3 Transcription Factor | 2 | 2019 | 80 | 0.210 |
Why?
|
Acetylation | 4 | 2020 | 94 | 0.210 |
Why?
|
Analysis of Variance | 2 | 2014 | 528 | 0.210 |
Why?
|
Microarray Analysis | 2 | 2014 | 61 | 0.200 |
Why?
|
Benzimidazoles | 1 | 2021 | 36 | 0.200 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 649 | 0.200 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2020 | 41 | 0.200 |
Why?
|
Exosomes | 2 | 2020 | 97 | 0.200 |
Why?
|
Zebrafish | 1 | 2022 | 118 | 0.200 |
Why?
|
Transfection | 5 | 2019 | 496 | 0.200 |
Why?
|
SOXB1 Transcription Factors | 1 | 2020 | 10 | 0.200 |
Why?
|
Forkhead Transcription Factors | 1 | 2021 | 74 | 0.200 |
Why?
|
Latin America | 1 | 2020 | 41 | 0.200 |
Why?
|
Organic Cation Transport Proteins | 1 | 2020 | 12 | 0.190 |
Why?
|
Mesalamine | 1 | 2020 | 2 | 0.190 |
Why?
|
Diverticulitis | 1 | 2020 | 2 | 0.190 |
Why?
|
Occult Blood | 1 | 2020 | 25 | 0.190 |
Why?
|
Hedgehog Proteins | 1 | 2021 | 45 | 0.190 |
Why?
|
Serotonin | 1 | 2021 | 114 | 0.190 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 58 | 0.190 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 74 | 0.190 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2020 | 242 | 0.190 |
Why?
|
Anal Canal | 1 | 2020 | 28 | 0.190 |
Why?
|
Mexico | 1 | 2021 | 223 | 0.190 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2020 | 18 | 0.190 |
Why?
|
Liver Function Tests | 1 | 2020 | 18 | 0.190 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 142 | 0.190 |
Why?
|
Interferons | 1 | 2020 | 34 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 52 | 0.190 |
Why?
|
Up-Regulation | 4 | 2019 | 490 | 0.190 |
Why?
|
Cannabidiol | 1 | 2019 | 3 | 0.180 |
Why?
|
DNA Damage | 2 | 2020 | 341 | 0.180 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 10 | 0.180 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 86 | 0.180 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 137 | 0.180 |
Why?
|
Iridoids | 1 | 2019 | 5 | 0.180 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 6 | 0.180 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2019 | 5 | 0.180 |
Why?
|
Quality of Health Care | 1 | 2020 | 136 | 0.180 |
Why?
|
DNA | 1 | 2022 | 549 | 0.180 |
Why?
|
NF-kappa B | 4 | 2015 | 306 | 0.170 |
Why?
|
Gastritis, Atrophic | 1 | 2019 | 10 | 0.170 |
Why?
|
Protein Disulfide-Isomerases | 1 | 2019 | 12 | 0.170 |
Why?
|
Cholecalciferol | 1 | 2019 | 19 | 0.170 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 96 | 0.170 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 211 | 0.170 |
Why?
|
Oman | 2 | 2008 | 6 | 0.170 |
Why?
|
Viral Load | 1 | 2020 | 300 | 0.170 |
Why?
|
Feasibility Studies | 1 | 2019 | 196 | 0.170 |
Why?
|
Enzyme Inhibitors | 2 | 2019 | 396 | 0.160 |
Why?
|
STAT Transcription Factors | 1 | 2017 | 10 | 0.160 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 555 | 0.160 |
Why?
|
Smoking | 2 | 2019 | 903 | 0.160 |
Why?
|
Mice, Nude | 4 | 2020 | 323 | 0.160 |
Why?
|
Janus Kinases | 1 | 2017 | 19 | 0.160 |
Why?
|
Severity of Illness Index | 1 | 2020 | 608 | 0.160 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 63 | 0.160 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 97 | 0.150 |
Why?
|
Treatment Outcome | 1 | 2021 | 1349 | 0.150 |
Why?
|
Phosphoproteins | 1 | 2018 | 154 | 0.150 |
Why?
|
E1A-Associated p300 Protein | 1 | 2016 | 9 | 0.150 |
Why?
|
Hydrazines | 1 | 2016 | 21 | 0.150 |
Why?
|
Sex Distribution | 1 | 2017 | 212 | 0.150 |
Why?
|
Colonoscopes | 1 | 2016 | 2 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2017 | 66 | 0.150 |
Why?
|
Interferon-gamma | 1 | 2017 | 235 | 0.150 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 2561 | 0.150 |
Why?
|
Hyperplasia | 1 | 2016 | 38 | 0.140 |
Why?
|
Adolescent | 4 | 2023 | 5035 | 0.140 |
Why?
|
SEER Program | 1 | 2016 | 87 | 0.140 |
Why?
|
Curcumin | 1 | 2016 | 66 | 0.140 |
Why?
|
Peptide Fragments | 1 | 2018 | 298 | 0.140 |
Why?
|
Alcohol Drinking | 2 | 2013 | 490 | 0.140 |
Why?
|
Statistics, Nonparametric | 2 | 2013 | 106 | 0.140 |
Why?
|
Mucins | 2 | 2008 | 33 | 0.140 |
Why?
|
DNA, Fungal | 3 | 1992 | 40 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 355 | 0.130 |
Why?
|
Rectum | 2 | 2019 | 22 | 0.130 |
Why?
|
Gastrins | 1 | 2015 | 9 | 0.130 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 794 | 0.130 |
Why?
|
Immunoblotting | 2 | 2008 | 170 | 0.130 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 27 | 0.130 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2014 | 2 | 0.130 |
Why?
|
Endoscopy | 1 | 2014 | 15 | 0.130 |
Why?
|
bcl-2-Associated X Protein | 2 | 2005 | 72 | 0.130 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2014 | 2 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2014 | 19 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2005 | 29 | 0.120 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 16 | 0.120 |
Why?
|
RNA, Untranslated | 1 | 2014 | 42 | 0.120 |
Why?
|
Cell Cycle Proteins | 3 | 2023 | 220 | 0.120 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2014 | 4 | 0.120 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2014 | 7 | 0.120 |
Why?
|
MAP Kinase Signaling System | 3 | 2021 | 162 | 0.120 |
Why?
|
Hypertension | 1 | 2021 | 770 | 0.120 |
Why?
|
rho-Associated Kinases | 1 | 2014 | 30 | 0.120 |
Why?
|
Metagenomics | 1 | 2013 | 32 | 0.120 |
Why?
|
Cell Cycle | 4 | 2015 | 309 | 0.120 |
Why?
|
Transcriptional Activation | 1 | 2014 | 164 | 0.120 |
Why?
|
Hydroxamic Acids | 1 | 2013 | 30 | 0.120 |
Why?
|
Genetic Association Studies | 1 | 2014 | 102 | 0.120 |
Why?
|
Cell Division | 3 | 2010 | 296 | 0.120 |
Why?
|
Age Distribution | 1 | 2013 | 223 | 0.110 |
Why?
|
Hospitals, General | 1 | 2012 | 7 | 0.110 |
Why?
|
Deoxyribonucleases | 1 | 2013 | 25 | 0.110 |
Why?
|
Receptor, erbB-2 | 1 | 2014 | 122 | 0.110 |
Why?
|
Nucleic Acid Hybridization | 2 | 2010 | 67 | 0.110 |
Why?
|
Gastroscopy | 1 | 2012 | 7 | 0.110 |
Why?
|
Genomic Instability | 1 | 2013 | 34 | 0.110 |
Why?
|
Endothelin-2 | 1 | 2012 | 1 | 0.110 |
Why?
|
Endothelin-3 | 1 | 2012 | 1 | 0.110 |
Why?
|
Homeostasis | 1 | 2014 | 172 | 0.110 |
Why?
|
Phycomyces | 1 | 1992 | 1 | 0.110 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2012 | 4 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 14 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2012 | 30 | 0.110 |
Why?
|
Gene Expression | 2 | 2018 | 639 | 0.110 |
Why?
|
Amino Acids | 1 | 2013 | 139 | 0.110 |
Why?
|
Paneth Cells | 1 | 2012 | 2 | 0.110 |
Why?
|
PPAR gamma | 1 | 2012 | 49 | 0.110 |
Why?
|
Ribonucleoproteins | 1 | 2012 | 29 | 0.110 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 968 | 0.110 |
Why?
|
Quercetin | 1 | 2012 | 41 | 0.110 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 17 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2024 | 97 | 0.110 |
Why?
|
Catalase | 2 | 2024 | 106 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2005 | 217 | 0.110 |
Why?
|
Metaplasia | 2 | 2023 | 34 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 133 | 0.100 |
Why?
|
Introns | 1 | 2012 | 67 | 0.100 |
Why?
|
Exons | 1 | 2012 | 80 | 0.100 |
Why?
|
Gene Knockdown Techniques | 3 | 2019 | 161 | 0.100 |
Why?
|
3' Untranslated Regions | 1 | 2012 | 67 | 0.100 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2011 | 9 | 0.100 |
Why?
|
Length of Stay | 1 | 2012 | 184 | 0.100 |
Why?
|
Gene Frequency | 1 | 2012 | 155 | 0.100 |
Why?
|
Dictyostelium | 2 | 1989 | 42 | 0.100 |
Why?
|
Glutamate Plasma Membrane Transport Proteins | 1 | 2011 | 2 | 0.100 |
Why?
|
Gene Fusion | 1 | 2011 | 6 | 0.100 |
Why?
|
Mortality | 1 | 2012 | 150 | 0.100 |
Why?
|
Seasons | 1 | 2011 | 112 | 0.100 |
Why?
|
Reactive Oxygen Species | 3 | 2016 | 416 | 0.100 |
Why?
|
Longevity | 1 | 2012 | 143 | 0.100 |
Why?
|
Complement C9 | 1 | 2010 | 2 | 0.100 |
Why?
|
Cathepsins | 1 | 2010 | 6 | 0.100 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 211 | 0.100 |
Why?
|
Alpha-Globulins | 1 | 2010 | 3 | 0.100 |
Why?
|
Genes, myc | 1 | 2010 | 28 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2013 | 301 | 0.100 |
Why?
|
Phosphorylation | 3 | 2021 | 878 | 0.100 |
Why?
|
Oncogenes | 2 | 2020 | 43 | 0.100 |
Why?
|
Cell Membrane | 2 | 2012 | 360 | 0.100 |
Why?
|
Membrane Proteins | 2 | 2012 | 486 | 0.090 |
Why?
|
Motor Activity | 1 | 2013 | 393 | 0.090 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2010 | 13 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 3 | 2018 | 185 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 286 | 0.090 |
Why?
|
Chromosomes, Human | 1 | 2010 | 31 | 0.090 |
Why?
|
Dependovirus | 1 | 1989 | 11 | 0.090 |
Why?
|
Host-Pathogen Interactions | 2 | 2024 | 179 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2011 | 213 | 0.090 |
Why?
|
DNA Primers | 2 | 2010 | 269 | 0.090 |
Why?
|
Genes, p16 | 1 | 2009 | 9 | 0.090 |
Why?
|
Nuclear Envelope | 1 | 2008 | 9 | 0.090 |
Why?
|
Proteome | 1 | 2010 | 132 | 0.090 |
Why?
|
Cell Fractionation | 1 | 2008 | 28 | 0.090 |
Why?
|
Neoplastic Stem Cells | 2 | 2020 | 74 | 0.090 |
Why?
|
Cell Death | 2 | 2020 | 260 | 0.080 |
Why?
|
Survival Analysis | 2 | 2020 | 322 | 0.080 |
Why?
|
Cytoplasm | 1 | 2008 | 135 | 0.080 |
Why?
|
Genetics, Population | 1 | 2008 | 66 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 184 | 0.080 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 72 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 325 | 0.080 |
Why?
|
Isotope Labeling | 3 | 2013 | 27 | 0.080 |
Why?
|
Outpatients | 2 | 2019 | 33 | 0.080 |
Why?
|
Plasmids | 1 | 1988 | 233 | 0.080 |
Why?
|
Homocysteine | 1 | 2007 | 18 | 0.080 |
Why?
|
Vitamin B 12 | 1 | 2007 | 19 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 136 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 445 | 0.070 |
Why?
|
Aging | 1 | 2011 | 639 | 0.070 |
Why?
|
Vitamins | 1 | 2007 | 91 | 0.070 |
Why?
|
Cell Nucleus | 1 | 1988 | 351 | 0.070 |
Why?
|
Peptic Ulcer | 1 | 2005 | 9 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 2 | 2021 | 173 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2018 | 897 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 605 | 0.060 |
Why?
|
Base Sequence | 3 | 2012 | 932 | 0.060 |
Why?
|
Histocompatibility Antigens | 1 | 2023 | 12 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 430 | 0.060 |
Why?
|
Herpesvirus 4, Human | 1 | 2024 | 33 | 0.060 |
Why?
|
Virus Activation | 1 | 2024 | 35 | 0.060 |
Why?
|
Nucleosomes | 2 | 2017 | 27 | 0.060 |
Why?
|
Cobalt | 2 | 2016 | 23 | 0.060 |
Why?
|
Ceramides | 1 | 2024 | 41 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 30 | 0.060 |
Why?
|
ROC Curve | 2 | 2016 | 138 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 282 | 0.060 |
Why?
|
HIV Infections | 1 | 2017 | 2207 | 0.060 |
Why?
|
RNA, Neoplasm | 2 | 2014 | 25 | 0.060 |
Why?
|
Carcinoembryonic Antigen | 1 | 2022 | 4 | 0.060 |
Why?
|
Fatigue | 1 | 2023 | 79 | 0.060 |
Why?
|
Peptide Termination Factors | 1 | 2022 | 3 | 0.060 |
Why?
|
Wnt Proteins | 1 | 2022 | 20 | 0.060 |
Why?
|
Haplorhini | 1 | 2002 | 21 | 0.050 |
Why?
|
Caspase 9 | 1 | 2002 | 27 | 0.050 |
Why?
|
Prostate | 1 | 2023 | 136 | 0.050 |
Why?
|
Vimentin | 1 | 2022 | 32 | 0.050 |
Why?
|
Caspase 8 | 1 | 2002 | 31 | 0.050 |
Why?
|
Rats | 3 | 2017 | 3261 | 0.050 |
Why?
|
Calcium Signaling | 1 | 2003 | 95 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 984 | 0.050 |
Why?
|
Genomics | 1 | 2023 | 201 | 0.050 |
Why?
|
Embryonic Development | 1 | 2022 | 73 | 0.050 |
Why?
|
CDC2 Protein Kinase | 1 | 2021 | 17 | 0.050 |
Why?
|
Caspase 3 | 1 | 2002 | 194 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2021 | 30 | 0.050 |
Why?
|
Helicobacter felis | 1 | 2021 | 2 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2002 | 423 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 33 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2000 | 392 | 0.050 |
Why?
|
Cyclin E | 1 | 2000 | 13 | 0.050 |
Why?
|
Propidium | 1 | 2000 | 18 | 0.050 |
Why?
|
Protein Conformation | 1 | 2021 | 350 | 0.050 |
Why?
|
Cyclins | 1 | 2000 | 35 | 0.050 |
Why?
|
Isoenzymes | 1 | 2001 | 149 | 0.050 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 140 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 54 | 0.050 |
Why?
|
Pinocytosis | 1 | 2020 | 8 | 0.050 |
Why?
|
Coloring Agents | 1 | 2000 | 51 | 0.050 |
Why?
|
Mass Spectrometry | 2 | 2013 | 255 | 0.050 |
Why?
|
Mice, SCID | 1 | 2020 | 143 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2020 | 136 | 0.050 |
Why?
|
Glutathione Peroxidase | 1 | 2000 | 109 | 0.050 |
Why?
|
Probiotics | 1 | 2020 | 25 | 0.050 |
Why?
|
Protein Binding | 2 | 2014 | 913 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2003 | 1442 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 36 | 0.050 |
Why?
|
Integrins | 1 | 2020 | 49 | 0.050 |
Why?
|
Calcium | 2 | 2019 | 445 | 0.050 |
Why?
|
Cathartics | 1 | 2019 | 6 | 0.050 |
Why?
|
Superoxide Dismutase | 1 | 2000 | 149 | 0.050 |
Why?
|
Genes, ras | 1 | 2019 | 22 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2003 | 562 | 0.050 |
Why?
|
Colon, Ascending | 1 | 2019 | 2 | 0.040 |
Why?
|
Colon, Transverse | 1 | 2019 | 2 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2019 | 3 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2019 | 31 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 43 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2019 | 71 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 80 | 0.040 |
Why?
|
Gene Targeting | 1 | 2019 | 39 | 0.040 |
Why?
|
Culture Media | 1 | 1999 | 84 | 0.040 |
Why?
|
Acetylglucosaminidase | 1 | 2019 | 2 | 0.040 |
Why?
|
Cathelicidins | 1 | 2019 | 2 | 0.040 |
Why?
|
Gastrectomy | 1 | 2019 | 9 | 0.040 |
Why?
|
Perception | 1 | 2020 | 183 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1999 | 59 | 0.040 |
Why?
|
Acid Phosphatase | 1 | 2019 | 19 | 0.040 |
Why?
|
Transient Receptor Potential Channels | 1 | 2019 | 7 | 0.040 |
Why?
|
Cell Count | 1 | 1999 | 129 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 1124 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2019 | 76 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2018 | 114 | 0.040 |
Why?
|
Cytidine Deaminase | 1 | 2018 | 31 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2018 | 53 | 0.040 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2019 | 33 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 89 | 0.040 |
Why?
|
Clathrin | 1 | 2018 | 19 | 0.040 |
Why?
|
Receptor, IGF Type 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
Models, Biological | 1 | 2021 | 642 | 0.040 |
Why?
|
Azepines | 1 | 2018 | 17 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 142 | 0.040 |
Why?
|
Microbial Viability | 1 | 2018 | 35 | 0.040 |
Why?
|
Antibody Affinity | 1 | 2018 | 25 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2020 | 254 | 0.040 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 33 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2017 | 19 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 104 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2017 | 122 | 0.040 |
Why?
|
Triazoles | 1 | 2018 | 85 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2017 | 4 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2017 | 121 | 0.040 |
Why?
|
Colombia | 1 | 2017 | 19 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2010 | 901 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 376 | 0.040 |
Why?
|
Infant | 1 | 2020 | 1014 | 0.040 |
Why?
|
Protein Transport | 1 | 2018 | 286 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 145 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2018 | 342 | 0.040 |
Why?
|
Genetic Loci | 1 | 2017 | 70 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2016 | 87 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2017 | 126 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 150 | 0.040 |
Why?
|
Solubility | 1 | 2016 | 115 | 0.040 |
Why?
|
Area Under Curve | 1 | 2016 | 91 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2017 | 117 | 0.040 |
Why?
|
Binding Sites | 1 | 2018 | 597 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 181 | 0.030 |
Why?
|
Receptor, Cholecystokinin B | 1 | 2015 | 9 | 0.030 |
Why?
|
Receptors, Growth Factor | 1 | 2015 | 13 | 0.030 |
Why?
|
Peptides | 1 | 2018 | 308 | 0.030 |
Why?
|
Models, Molecular | 1 | 2018 | 751 | 0.030 |
Why?
|
Escherichia coli | 1 | 2018 | 436 | 0.030 |
Why?
|
Nod1 Signaling Adaptor Protein | 1 | 2014 | 1 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2014 | 1 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 41 | 0.030 |
Why?
|
I-kappa B Proteins | 1 | 2014 | 38 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2014 | 62 | 0.030 |
Why?
|
Hospitals | 1 | 2014 | 86 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2013 | 72 | 0.030 |
Why?
|
Proprotein Convertases | 1 | 2013 | 8 | 0.030 |
Why?
|
Mannose-Binding Lectins | 1 | 2013 | 14 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2013 | 36 | 0.030 |
Why?
|
Protestantism | 1 | 2012 | 5 | 0.030 |
Why?
|
Isoelectric Focusing | 1 | 2012 | 16 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 195 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 1534 | 0.030 |
Why?
|
1-Propanol | 1 | 1992 | 2 | 0.030 |
Why?
|
Chloroform | 1 | 1992 | 3 | 0.030 |
Why?
|
Chemical Precipitation | 1 | 1992 | 8 | 0.030 |
Why?
|
Anilides | 1 | 2012 | 27 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2013 | 151 | 0.030 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1992 | 27 | 0.030 |
Why?
|
HT29 Cells | 1 | 2012 | 40 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 88 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2012 | 48 | 0.030 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2012 | 12 | 0.030 |
Why?
|
Drug Synergism | 1 | 2012 | 171 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 1992 | 81 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 49 | 0.030 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2011 | 25 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 406 | 0.020 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2010 | 13 | 0.020 |
Why?
|
Densitometry | 1 | 2010 | 13 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2010 | 37 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 105 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 1003 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2010 | 45 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 87 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 228 | 0.020 |
Why?
|
Blood Proteins | 1 | 2010 | 65 | 0.020 |
Why?
|
Genes, Dominant | 1 | 1989 | 18 | 0.020 |
Why?
|
Imidazoles | 1 | 2010 | 124 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 1989 | 26 | 0.020 |
Why?
|
Carcinogens | 1 | 2010 | 117 | 0.020 |
Why?
|
KB Cells | 1 | 1989 | 7 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1989 | 30 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 165 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 1989 | 142 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1988 | 154 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 1989 | 1490 | 0.020 |
Why?
|
Phospholipases A | 1 | 2003 | 8 | 0.010 |
Why?
|
Phospholipases A2 | 1 | 2003 | 8 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2003 | 19 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2003 | 42 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 2003 | 57 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 2003 | 88 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2001 | 160 | 0.010 |
Why?
|
Histamine H2 Antagonists | 1 | 1999 | 3 | 0.010 |
Why?
|
Ranitidine | 1 | 1999 | 4 | 0.010 |
Why?
|
Bismuth | 1 | 1999 | 3 | 0.010 |
Why?
|
Clarithromycin | 1 | 1999 | 8 | 0.010 |
Why?
|
Metronidazole | 1 | 1999 | 13 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1999 | 145 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1992 | 21 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1992 | 186 | 0.010 |
Why?
|
Multigene Family | 1 | 1992 | 105 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1992 | 128 | 0.010 |
Why?
|
Extrachromosomal Inheritance | 1 | 1989 | 2 | 0.010 |
Why?
|
Electrophoresis | 1 | 1989 | 22 | 0.010 |
Why?
|